Forte Biosciences, Inc.FBRXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-30.78M
↓ 37% below average
Average (9y)
$-22.54M
Historical baseline
Range
High:$-2.93M
Low:$-36.44M
CAGR
+4.2%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-30.78M | -6.9% |
| 2023 | $-28.79M | -251.8% |
| 2022 | $-8.19M | +50.9% |
| 2021 | $-16.68M | +9.5% |
| 2020 | $-18.42M | -528.1% |
| 2019 | $-2.93M | +92.0% |
| 2018 | $-36.44M | -14.6% |
| 2017 | $-31.79M | -5.7% |
| 2016 | $-30.06M | -41.3% |
| 2015 | $-21.27M | - |